BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38430737)

  • 1. Establishment of a transgene-free iPS cell line (SDCHi003-A) from a young patient bearing a NPRL2 mutation and suffering from Epilepsy.
    Su S; Zhao F; Zhang H; Liu Y; Li Z; Zhang H; Wang Y; Fang F; Liu Y
    Stem Cell Res; 2024 Apr; 76():103366. PubMed ID: 38430737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a transgene-free iPS cell line (SDQLCHi046-A) from a young patient bearing a HDAC8 mutation and suffering from Cornelia de Lange Syndrome.
    Li Z; Liu C; Xin H; Yang Y; Wang Y; Niu S; Gao C; Gai Z; Liu Y
    Stem Cell Res; 2023 Feb; 66():102984. PubMed ID: 36481505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A.
    Zhang Y; Li A; Huang CL; Wang G; Wang D
    Stem Cell Res; 2019 Aug; 39():101509. PubMed ID: 31382203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An achievement has been made in establishing an induced pluripotent stem cell line (SDPHi005-A) from a healthy Chinese male donor.
    Shao J; Jin Y; Shao C; Zhang X; Yang G
    Stem Cell Res; 2024 Jun; 77():103393. PubMed ID: 38531229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells.
    Gao Y; Cheng Y; Wen J; Xiao D; Xu J; Cai C; Hu J
    Stem Cell Res; 2023 Jun; 69():103088. PubMed ID: 37099933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
    Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
    Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer.
    Ai D; Yang X; Li X; Liu N; Xie X; Liu Y; Song W
    Stem Cell Res; 2023 Jun; 69():103096. PubMed ID: 37104933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
    Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
    Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female.
    Nimonkar MM; Arunachal G; Dash SS; Kandy SK; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
    Stem Cell Res; 2023 Aug; 70():103130. PubMed ID: 37269666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors.
    Vlahos K; Sourris K; Yi Kuah J; Graham A; Suter A; Howden SE; Stanley EG; Elefanty AG
    Stem Cell Res; 2023 Jun; 69():103109. PubMed ID: 37150143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an erythroid progenitor-derived iPSC line, VRISGi002-A, from a healthy 27-year-old Vietnamese donor under a feeder-free system.
    Nhung Nguyen TH; Trinh Tran TT; Luong TH; Nguyen XH
    Stem Cell Res; 2022 Jul; 62():102824. PubMed ID: 35679757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of PLAFMCi004-A induced pluripotent stem cells derived from PBMCs from a healthy individual.
    Shang S; Chen K; Cai G; Bai X; Chen X; Li Q
    Stem Cell Res; 2021 May; 53():102316. PubMed ID: 33878710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of the iPS cell line (SYSUSHi001-A) derived from the peripheral blood mononuclear cells (PBMCs) of a 33-year-old patient with acute myeloid leukemia (AML).
    Yuan L; Xie M; Tao Y; Chen X; Xu X; Wang X
    Stem Cell Res; 2024 Jun; 77():103360. PubMed ID: 38608356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of induced pluripotent stem cell line SDPHi003-A from a healthy male donor.
    Xi Y; Zhang H; Yang X; Ai D; Liu Y; Song W
    Stem Cell Res; 2023 Sep; 71():103160. PubMed ID: 37429069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient generation of induced pluripotent stem cell lines from healthy donors' peripheral blood mononuclear cells of different genders.
    Gao Y; Cheng Y; Lin B; Xiao D; Wen J; Xu J; Zheng R; Zhang M; Cai C; Hu J
    Stem Cell Res; 2024 Jun; 77():103421. PubMed ID: 38636268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an induced pluripotent stem cell line (GWCMCi005-A) from a patient with Lennox-Gastaut syndrome carrying TANC2 Gln1441Ter mutation.
    Tian Y; Shi Z; Liao Y; Cai J; Li W; Li X; Chen WX
    Stem Cell Res; 2022 Apr; 60():102667. PubMed ID: 35066241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of iPS cell line (SYSUSHi002-A) from PBMCs of an AML patient with TP53 mutation.
    Yuan L; Wang Y; Xie R; Lin D; Wang X
    Stem Cell Res; 2023 Dec; 73():103230. PubMed ID: 37890328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem Cells.
    Kimura K; Tsukamoto M; Tanaka M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Sugiura K; Hatoya S
    Stem Cells Dev; 2021 Jan; 30(2):79-90. PubMed ID: 33256572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
    Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
    Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.